VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1224277
Sex: M
Age:
State: PA

Vax Date: 03/26/2021
Onset Date:
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Today, the test was positive; This is a spontaneous case received report from a contactable consumer or other non hcp. A male patient of an unspecified age (61 age unit unknown) received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 26Mar2021 (Batch/Lot Number: ER8733) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced today; the test was positive (pending clarification) on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included lab test: positive on 30Mar2021. The action taken in response to the event(s) for bnt162b2 was not applicable.

Other Meds:

Current Illness:

ID: 1224278
Sex: F
Age:
State: NY

Vax Date: 03/17/2021
Onset Date: 03/28/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lump on the left clavicle, suspected to be lymphatic swelling; This is a spontaneous report from a contactable consumer (Patient). A 33-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot# ER2G13), via an unspecified route of administration in left arm on 17Mar2021 at 2.45 PM (at the age of 33 years-of-old) at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 28Mar2021, patient experienced lump on the left clavicle, suspected to be lymphatic swelling. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if the patient received any treatment for the event. It was unknown if the patient had COVID prior vaccination. The patient was not tested for COVID post vaccination. The outcome of the event was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1224279
Sex: F
Age:
State: PA

Vax Date: 03/07/2021
Onset Date: 03/22/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Felt exhaustion the following day and evening.; woke up at 1 am with aches pains and a slight fever; woke up at 1 am with aches pains and a slight fever; This is a spontaneous report from a contactable consumer. A 32-years-old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 07Mar2021 (Batch/Lot Number: EN6199) as SINGLE DOSE for covid-19 immunization. Other medical history was none. There were no concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Allergies to medications, food, or other products was none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications were received within 2 weeks of vaccination. On 22Mar2021 01:00AM, the patient woke up at 1 am with aches pains and a slight fever. Felt exhaustion the following day (23Mar2021) and evening. The patient received second dose of BNT162B2 (Lot number EP6955) via an unspecified route of administration, administered in Arm Left on 28Mar2021 10:30 PM as SINGLE DOSE for covid-19 immunization. The events were assessed as non-serious. No treatment received for the adverse event. Outcome of the events was recovered in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1224280
Sex: M
Age:
State: AZ

Vax Date: 03/20/2021
Onset Date: 03/30/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive COVID; This is a spontaneous report from a contactable consumer. A 37-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER2613), dose 1 administered via intramuscular route of administration on arm left on 20Mar2021 at 12:00 as single dose for covid-19 immunization. Medical history reported that patient is overweight but has not diagnosed with diabetes, has a lot of symptoms though, seasonal allergies and was really young around 14-15 and had two surgeries for it. One surgery at age 16 and another later to deal with it. All prior to getting the vaccine and family medical history: Diabetes. Concomitant medications were not reported. On 30Mar2021, the patient tested covid positive and scheduled to get second dose in 13 days and is not sure what to do. He would like to get some guidance about when to get second dose. Outcome of event was unknown.

Other Meds:

Current Illness:

ID: 1224281
Sex: M
Age:
State: AR

Vax Date: 03/13/2021
Onset Date: 03/01/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cough; chills; nausea; This is a spontaneous report from a contactable consumer (patient) reported for himself. This 55-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 13Mar2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient received the first dose of the vaccine on 13Mar2021, and was scheduled for the second dose this Saturday. This last week (unspecified date in Mar2021), patient had been experiencing cough, chills and nausea when he was about to eat. The outcome of events was unknown. No follow-up attempts are possible; Information about batch/Lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1224282
Sex: F
Age:
State: IL

Vax Date: 03/15/2021
Onset Date: 03/29/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: very weak; Caller states her mom was diagnosed with COVID-19 yesterday/Received first dose on 15Mar2021; diagnosed with Covid on 29Mar2021; Caller states her mom was diagnosed with COVID-19 yesterday/Received first dose on 15Mar2021; diagnosed with Covid on 29Mar2021; This is a spontaneous report from a contactable consumer or other non HCP. A 70-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 15Mar2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Caller stated that her mom was scheduled to receive the second dose on 02Apr2021. Her mom was diagnosed with COVID-19 on 29Mar2021. The patient had called (health department name) and they told her that her mother should wait 90 days to receive the second dose and then she would have to restart the series. The reporter would like to know what guidance there was for people who are diagnosed with COVID between doses and receiving their second doses and would like to know what the maximum amount of time is you should not go over between the first and second dose of the Pfizer COVID vaccine. Her mother's doctor doesn't know, nobody knows, if they need to reschedule her second vaccine. The patient just wanted to know what was right, Wants to know when her mom can get the second vaccine, if she has to start over. Caller declines to complete safety report. States she has been on hold for 45 minutes and was on hold prior to that with someone else. She stated they took down all of her information and that she just wants to get her question answered and Caller stated she did not have the Lot number from her mom's vaccine as it is with her mom who was not with the caller at this time, declined to provide mailing address and stated that its already been given to previous department she was speaking with. Caller was concerned because her mother will be placed under a 14-day quarantine and she was not sure on how her mother will receive the 2nd vaccine or whether her mother will repeat the entire process of vaccination because her mother was very weak and will still be on quarantine on the 2nd dose vaccination appointment. The outcome of the events was unknown. Follow-up (30Mar2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported for a patient (Reporter's mom) that: patient was diagnosed with COVID on 29Mar2021. Follow-up (30Mar2021): This is a Follow-up spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a patient (Reporter's mother) new event asthenia. Information about Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 1224283
Sex: F
Age:
State: AZ

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Rapid heartbeat; Body aches; Dizziness; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received the second dose bnt162b2 (Pfizer, Lot Number: EP69SS) on 30Mar2021 01:30 PM at the age of 64-year-old as single dose for COVID-19 immunisation in left arm. The patient was not pregnant at the time of event and vaccination. Medical history included anxiety, and was allergy to Septra. Concomitant medications received within 2 weeks of vaccination included duloxetine, calcium, magnesium, vitamin D. The patient had taken the first dose COVID 19 Vaccine (Pfizer, Lot number: EN6206) on 08Mar2021 for COVID-19 immunisation in left arm. The patient was not diagnosed with COVID-19 prior to vaccination, and hasn't been tested for COVID-19 since the vaccination. The patient experienced non-serious events: headache, rapid heartbeat, body aches, dizziness on 30Mar2021 10:00 PM with outcome of not recovered. No treatment received for the events. No follow-up attempts are possible. No further information is expected.

Other Meds: DULOXETINE; CALCIUM; MAGNESIUM; VITAMIN D NOS

Current Illness:

ID: 1224284
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: he had a bad fever; This is a spontaneous report from a contactable consumer. A contactable consumer of 60-years-old male patient (himself) reported for himself that received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that after receiving first dose of vaccine he experienced a bad fever on an unspecified date that lasted for half an hour. He wanted to know if this is normal. He wondered if he could take the second dose as he heard that some people had worse reactions after the first dose if they had COVID in the past. She wondered if she could take Tylenol before vaccination. The outcome of the event was unknown. Information about batch/lot number is not provided. No further information is expected.

Other Meds:

Current Illness:

ID: 1224285
Sex: M
Age:
State: OH

Vax Date: 03/25/2021
Onset Date:
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sleep for a few minutes, I didn't pass out but it was similar; Was pulled over "for minor traffic violation." He was told "to get out of the car and had a field sobriety test, and I looked intoxicated."; Felt heavy and tired/Run down; Had a headache; Upset stomach; sleep for a few minutes, I didn't pass out but it was similar/crashed for 4-5 hours in the middle of the day which I never do; aching; Over all weakness; Started feeling sick again at dinner; Woke up feeling really bad; Bad diarrhea; This is a spontaneous report from a contactable consumer or other non hcp. A 41-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 25Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing Allergic to sulfa, PCN and amoxicillin. The patients concomitant medications were not reported. On an unspecified date the patient experienced sleep for a few minutes, I didnt pass out but it was similar, was pulled over for minor traffic violation. He was told to get out of the car and had a field sobriety test, and I looked intoxicated, felt heavy and tired/run down, had a headache, bad diarrhea, upset stomach, sleep for a few minutes, I didnt pass out but it was similar, crashed for 4 to 5 hours in the middle of the day which I never do, aching, overall weakness, started feeling sick again at dinner, he went to the bathroom a few times, woke up feeling really bad. The patient was worried because everything was coming to a head right now. The caller got the first shot, he waited for 15 minutes and felt fine. As the caller walked to his car he began feeling heavy, had severe diarrhea, headache, aching, it was almost like he passed out, it felt like he went to sleep. The patient got home and crashed 4 to 5 hours in the middle of the day and woke up feeling really bad. The patient went to a very important dinner meeting that night. While the patient was at the meeting he went to the bathroom a few times and then excused himself because he felt so bad. The patient did not even finish one cocktail with dinner. The caller got pulled over for a minor traffic stop, cutting the corner and crossing the line or something small. The officers believed the caller was driving under the influence and started making him do a sobriety test with 40 degree wind gusts, the patient was miserable. The caller told the officers that he needed to seek medical attention but they ignored him. The officers forced the caller to do the urine test. It has been 5 days since his vaccination and he is just now feeling better. The outcome of events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1224286
Sex: F
Age:
State: RI

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme fatigue in arm that shot was administered in; This is a spontaneous report from a contactable consumer (patient). A 41-years-old non pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 26Mar2021 16:30 (Batch/Lot Number: ER8732) as SINGLE DOSE for covid-19 immunization. No other medical history. There were no concomitant medications. The patient previously received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 05Mar2021 04:00 PM (Batch/Lot Number: EN6199) as SINGLE DOSE for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications were not received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.: No Allergies to medications, food, or other products. On 27Mar2021 03:00 PM, the patient Extreme fatigue in arm that shot was administered in. The event was assessed as non-serious. No treatment received for the adverse event. Outcome of the event was recovered in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1224287
Sex: F
Age:
State: VA

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: More swelling in left hand; Increase in joint pain; Common cold symptoms; Right ear felt weird; Increase blood pressure within 15minutes of the injection; This is a spontaneous report received from a contactable consumer (reporting on herself). A 50-years-old Non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration in Arm Right on 23Mar2021 16:15, as SINGLE DOSE for covid-19 immunization. Medical history included rheumatoid arthritis, hypothyroidism, hypertension all from an unknown date and unknown if ongoing. Concomitant medication(s) included prednisone (PREDNISONE) and meloxicam (MELOXICAM) both taken for an unspecified indication, start and stop date were not reported. The historical vaccine includes flu vaccine on an unspecified date. Patient was not pregnant at the time of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. On 23-MAR-2021 18:00, more swelling in left hand, increase in joint pain, common cold symptoms, increase blood pressure Within 15minutes of the injection. Right ear felt weird. Patient was not received any treatment for the adverse reactions. Since the vaccination, patient was not tested for COVID-19. The outcome of the events recovered with sequelae. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: PREDNISONE; MELOXICAM

Current Illness:

ID: 1224288
Sex: M
Age:
State: OH

Vax Date: 03/26/2021
Onset Date: 03/29/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Ringing in both ears; patient previously was not diagnosed with tinnitus and did not have the moderate level disturbance patient have now.; This is a spontaneous report received from a contactable consumer. A 55-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: ER8727), via an unspecified route of administration, administered in left arm on 26Mar2021 15:15 (at 55-years age) as single dose for covid-19 immunization. Medical history included depression and patient was allergic to antibiotic Muscinex. Concomitant medication(s) included citalopram (CITALOPRAM) 40mg daily. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 29Mar2021 07:00 patient experienced ringing in both ears started 2 days after the injection and has not stopped as of the date of this report (30-Mar-2021). Patient previously was not diagnosed with tinnitus and did not have the moderate level disturbance patient had now. No treatment received for reported adverse event. Patient not tested for COVID-19 after the vaccination. The outcome of the events was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds: CITALOPRAM

Current Illness:

ID: 1224289
Sex: F
Age:
State: KY

Vax Date: 03/28/2021
Onset Date: 03/29/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 13 hours after receiving 2nd vaccine, woke up with chills, shaking, extreme muscle aches, headache and sinus drainage; 13 hours after receiving 2nd vaccine, woke up with chills, shaking, extreme muscle aches, headache and sinus drainage; 13 hours after receiving 2nd vaccine, woke up with chills, shaking, extreme muscle aches, headache and sinus drainage; 13 hours after receiving 2nd vaccine, woke up with chills, shaking, extreme muscle aches, headache and sinus drainage; 13 hours after receiving 2nd vaccine, woke up with chills, shaking, extreme muscle aches, headache and sinus drainage; This is a spontaneous report from a contactable consumer (patient). A 60-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ER2613), via an unspecified route of administration, administered in arm left on 28Mar2021 at 12:00 as single dose for COVID-19 immunization. Medical history included breast cancer from 2013 and blood cholesterol increased. The patient had allergy to sulfa. The patient previously received first dose of bnt162b2 (lot number: EN6202), in left arm on 07Mar2021 at 15:30 as single doses for COVID-19 immunization. Concomitant medication(s) (received within 2 weeks of vaccination) included atorvastatin, colecalciferol (VITAMIN D [COLECALCIFEROL]), ascorbic acid, betaine hydrochloride, boric acid, calcium carbonate, calcium citrate, calcium lactate, calcium pantothenate, calcium phosphate, citric acid, colecalciferol, copper gluconate, cyanocobalamin, folic acid, fumaric acid, magnesium aspartate, magnesium oxide, malic acid, manganese aspartate, menaquinone-7, nicotinamide, oxogluric acid, phytomenadione, pyridoxine hydrochloride, riboflavin, silicon dioxide, sodium molybdate, sodium selenite, strontium chloride, succinic acid, thiamine, zinc picolinate (OSTEOPRIME ULTRA). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 29Mar2021 at 03:00, the patient experienced 13 hours after receiving second dose, woke up with chills, shaking, extreme muscle aches, headache and sinus drainage. The patient did not receive treatment for the events. The outcome of events was recovering. No follow-up attempts are possible. No further information expected.

Other Meds: ATORVASTATIN; VITAMIN D [COLECALCIFEROL]; OSTEOPRIME ULTRA

Current Illness:

ID: 1224290
Sex: M
Age:
State: KS

Vax Date: 03/20/2021
Onset Date: 03/01/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Eustachian tube dysfunction; Eustachian tube dysfunction and tinnitus (constant high pitch squeal) in both ears/ It was sometimes louder than other times/ It becomes piercingly loud and painful when exposed to other loud noises; Eustachian tube dysfunction and tinnitus (constant high pitch squeal) in both ears/ It was sometimes louder than other times/ It becomes piercingly loud and painful when exposed to other loud noises; Soreness at the injection site; Frequent headaches (every 2 or 3 days); Sore throat started 2 days after injection; Dry throat and chills started a week after injection and current; Dry throat and chills started a week after injection; This is spontaneous report received from a contactable consumer (patient himself). A 43-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8730), via an unspecified route of administration in left arm on 20Mar2021 at 16:00 (at the age of 43-year-old) as a single dose for COVID-19 immunization. The patient's medical history was none. Concomitant medications were not reported. The patient did not have allergies to medications, food, or other products and no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Eustachian tube dysfunction and tinnitus (constant high pitch squeal) in both ears on 21Mar2021. It was sometimes louder than other times. It becomes piercingly loud and painful when exposed to other loud noises, started the day after the vaccine injection. Frequent headaches (every 2 or 3 days) started the day of the injection (20Mar2021) and current. Sore throat started 2 days after injection (on an unspecified date in Mar2021) and has decreased in the last few days. Dry throat and chills started a week after injection (on an unspecified date in Mar2021) and current. Soreness at the injection site on 21Mar2021 that went away after a few days. The adverse events resulted in doctor or other healthcare professional office/clinic visit. No treatment was received for the adverse events. The outcome of the event soreness at the injection site was recovered on an unspecified date in 2021, recovering for the event sore throat and not recovered for the other events. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1224291
Sex: F
Age:
State: GA

Vax Date: 03/29/2021
Onset Date: 03/01/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Very sore immediately in arm. Hurts to even lift it the slightest; very nauseous; stomach upset; loose bowels; This is a spontaneous report received from a contactable consumer (patient). A 46-year-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 29Mar2021 as single dose for COVID-19 immunization. Medical history included allergic to Hydrocodone. Concomitant medications (received within 2 weeks of vaccination) included levothyroxine sodium (LEVOXYL), bupropion hydrochloride (WELLBUTRIN), lamotrigine (LAMICTAL) and aprazalam. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the was not patient diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. In Mar2021, the patient experienced very sore immediately in arm, hurts to even lift it the slightest, very nauseous, stomach upset and loose bowels. It was unknown whether the patient was admitted to the hospital. No treatment received for the events. The outcome of the events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOXYL; WELLBUTRIN; LAMICTAL; ALPRAZOLAM

Current Illness:

ID: 1224292
Sex: M
Age:
State: MO

Vax Date: 03/11/2021
Onset Date: 03/13/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sweating; loss of appetite; diarrhea; vomitting lasted for a day; chills; could hardly eat anything for 5 days; This is a follow up spontaneous received from a contactable Consumer (patient). This 60-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (manufacturer: Unspecified) first dose on 11MAR2021 2 weeks ago (Lot: EN6207, NDC/UPC number: Unknown, Expiry Date: Unknown) at single dose for COVID-19 immunisation. Medical history included COPD, allergies, asthma, all from unspecified date to unspecified date and probably diagnosed from 10-15 years ago. Concomitant medications included Montelukast, Fluconazole, Trazodone for Muscle relaxant, tiotropium bromide (SPIRIVA), oxycodone hydrochloride (OXYCONTIN) for bad back and hip replacement and all of his pain medicine, Nebulizer at 2 times a day, all from unspecified date to unspecified date and other unspecified Concomitant Products. He took a sleeping pill at night so that he could sleep. He took 'Steopus' that was 2 times in the evening for his allergies. The patient previously took multivitamin at one dose every day for couple of months for low on some Vitamins. Received on 2021-03-30 19:21:32 UTC, Originating AE Request: REQ-219680. Submitted by Call Centre 1 Reference: W2021379399; PRIMA: 21-181755. Reporter was warm connected with agent with ID reportum number 542ANWOH. Reporter received the Pfizer covid vaccine, first dose 2 weeks ago and 3 days after that he had diarrhea, vomitting lasted for a day, chills, sweating, he could hardly eat anything for 5 days. The symptoms come and went but from yesterday he stated to feel better now. Probably about 13MAR2021 was when patient first had started with diarrhea and stuff and he vomited just for one day because he had quit eating so then giving up his appetite and from then it was like he would say, it had set off yesterday but he had had chills on and off possibly all day long and all night long, not really heavy heavy sweat but sweat and loss of appetite. Reported event seriousness was unspecified. When probed if the events are improved, worsened or persisting, the patient stated they were about gone now. He was scheduled for his second shot on the first of this month, not this month the coming month. He hoped his second won't be that bad, second shot was 01APR2021. The patient underwent lab tests and procedures, which included did a lab test month and they said he was low on some Vitamins. He was low in some vitamins, he thought. The outcomes of the events was Recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: MONTELUKAST; FLUCONAZOLE; TRAZODONE; SPIRIVA; OXYCONTIN

Current Illness:

ID: 1224293
Sex: F
Age:
State:

Vax Date: 03/10/2021
Onset Date: 03/15/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for COVID-19/fever and chills; bone pain; arm pain; This is spontaneous report from a contactable consumer (patient) via Medical information team. This consumer reported similar events for herself and 1 patient (reporter's husband). This is a 1st of two reports. A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration on 10Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient and her husband both tested positive for COVID-19 on 15Mar2021. Their second vaccination was originally scheduled for March 31, 2021. On 15Mar2021, the patient and her husband experienced fever and chills, the husband felt worse and had to go to a hospital, where he was diagnosed with COVID-19 and was prescribed "medicine for the chills." Then, the patient and one of their children also tested positive for COVID-19 but had no symptoms. They were recommended to stay isolated for 14 days. The patient experienced mild symptoms of arm pain, fever for 1 day, and bone pain after vaccination. She felt better after a couple of days, unlike her husband.The patient underwent lab tests and procedures which included COVID-19 (nasal swab) test: positive on 15Mar2021. The outcome of the events was recovering. Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : PFIZER INC-2021353312 same product and event, different patient

Other Meds:

Current Illness:

ID: 1224294
Sex: F
Age:
State: TX

Vax Date: 03/12/2021
Onset Date: 03/19/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pityriasis rosea; This is a spontaneous report received from a contactable consumer (patient). A 33-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6207), via an unspecified route of administration in left arm on 12Mar2021 18:00 as single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. Vaccination facility type- Clinic. The patient medical history and concomitant medications were not reported. The patient not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 19Mar2021, the patient experienced Pityriasis rosea, assessed as non-serious. Steroid cream was given as a treatment for the adverse event. The adverse event resulted for Doctor or other healthcare professional office/clinic visit. The outcome of the event was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1224295
Sex: F
Age:
State: TX

Vax Date: 03/06/2021
Onset Date: 03/06/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Excruciating pain that night in joints, bones, and nerves; Excruciating pain that night in joints, bones, and nerves; Excruciating pain that night in joints, bones, and nerves; Excruciating pain that night in joints, bones, and nerves; This is a spontaneous report received from a contactable consumer (reporting on herself). A 71-years-old Non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration in Arm Left on 06Mar2021 11:00, as SINGLE DOSE for covid-19 immunization. Medical history included nerve injury, osteoarthritis, cerebrovascular accident (stroke 5 years prior) and covid-19 (Prior to vaccination) all from an unknown date and unknown if ongoing. Concomitant medication(s) included levothyroxine sodium (LEVOTHYROXINE SODIUM); atorvastatin (ATORVASTATIN); gabapentin (GABAPENTIN); oxymetazoline hydrochloride (CLARITIN ALLERGIC) all taken for an unspecified indication, start and stop date were not reported. The patient previously took antibiotics for drug hypersensitivity and experienced drug hypersensitivity and have allergies to most antibiotics. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. It was reported that 06Mar2021 20:00 Excruciating pain that night in joints, bones, and nerves. Severe to moderate pain up to 13 days after injection. Patient did not receive any treatment for the events. Patient was not tested for COVID-19 post vaccination. The outcome of the events was recovering.

Other Meds: LEVOTHYROXINE SODIUM; ATORVASTATIN; GABAPENTIN; CLARITIN ALLERGIC

Current Illness:

ID: 1224296
Sex: F
Age:
State: PA

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tingly and numbing lower left side of my lip; numbing lower left side of my lip; Eye feel tired; Eye feel tired, low level pain behind them; slight sore throat on the left side; the standard arm feels heavy and a bit achy; This is an initial spontaneous report received from a contactable consumer. A female patient of an unspecified age received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Batch/Lot Number: ER8727), via an unspecified route of administration, administered in Arm Left on 30Mar2021 16:00 as single dose for COVID-19 immunization. Medical history included type 2 diabetes mellitus, seasonal allergy and allergy to animal from an unknown date and unknown if ongoing. Concomitant medications included metformin and dulaglutide taken for an unspecified indication, start and stop date were not reported. The patient experienced tingly and numbing lower left side of my lip, eye feeling tired, low level pain behind them, slight sore throat on the left side and the standard arm feels heavy and a bit achy on 30Mar2021 16:30. The outcome of the events was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; TRULICITY

Current Illness:

ID: 1224297
Sex: F
Age:
State:

Vax Date: 03/16/2021
Onset Date: 03/28/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: she tested positive this past weekend and got her results on sunday 28Mar2021; This is a spontaneous case received report from a non-contactable consumer or other non hcp. A 30-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 16Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced she tested positive this past weekend and got her results on sunday 28mar2021 (sars-cov-2 test positive) (medically significant) on 28Mar2021 with outcome of unknown. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 28Mar2021 Positive. The action taken in response to the event(s) for bnt162b2 was not applicable. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1224298
Sex: F
Age:
State: TX

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Increased mood instability; paranoia; This is a spontaneous report from a contactable consumer. A 29-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 29Mar2021 11:00 (At the age of 29-year-old) as SINGLE DOSE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included bipolar disorder, anxiety, post-traumatic stress disorder. Concomitant medication(s) included Effexor, Lamictal, abilify, trazodone. Allergies to medications, food, or other products: Sulfa drugs. On 29Mar2021 15:00 the patient experienced increased mood instability, paranoia. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19, Prior to vaccination. The patient has not tested for COVID-19, Since the vaccination. No treatment received. The seriousness was reported non-serious. The outcome of event was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: EFFEXOR; LAMICTAL; ABILIFY; TRAZODONE

Current Illness:

ID: 1224299
Sex: F
Age:
State: PA

Vax Date: 03/24/2021
Onset Date: 03/30/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cough; painful post nasal drip; headache; feel feverish but have no fever; This is a spontaneous report received from a contactable consumer. A 39-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date was not reported), via an unspecified route of administration, in left arm on 24Mar2021 14:15 as single dose for covid-19 immunization. Medical history included PCOS, ADHD, chronic fatigue, and allergic to penicillin, egg, dairy. Concomitant medication(s) included methylphenidate hydrochloride (CONCERTA), patient received these medications within 2 weeks of vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. 6 days later patient experienced a headache, cough and feel feverish but had no fever. Patient also had a painful postnasal drip on 30Mar2021 14:00. Patient not tested for COVID-19 after the vaccination. No treatment received for the reported adverse events. The outcome of the events was not resolved. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: CONCERTA

Current Illness:

ID: 1224300
Sex: M
Age:
State: PA

Vax Date: 03/28/2021
Onset Date: 03/28/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; sweats; headache; very tired, could not get out of bed; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer reported about a 44 year old male patient reported that the patient received the second dose of BNT162B2; Pfizer-BioNTech COVID-19 Vaccine; Lot number: EN6204; expiry date: unknown; Solution for injection);via an unspecified route of administration in the left arm on 28Mar2021 at 11:45 and received the first dose of Pfizer-BioNTech COVID-19 Vaccine; Lot number: EN6206; Solution for Injection) on 07Mar2021. The known allergies were Digestive allergies to Dairy and Gluten. The patient experienced chills, sweats, body aches, headache, very tired and could not get out on 28Mar2021 at 11:30 pm. The patient received Tetanus shot on 3/18, Prozac. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any treatment for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: TETANUS VACCINE; PROZAC

Current Illness:

ID: 1224301
Sex: M
Age:
State: WI

Vax Date: 03/21/2021
Onset Date: 03/21/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; dizziness; nausea; feeling unwell; tired; for three days injection site pain. Injection site pain started immediately; This is a spontaneous report from a contactable consumer (Patient) or other non hcp. A 75-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), dose 1 subcutaneous on 21Mar2021 11:00 as single dose for covid-19 immunisation.The patient's medical history and concomitant was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. The patient had no known allergies to medications, food, or other products. On 30Mar2021 06:30, he experienced Headache, dizziness, nausea, feeling unwell, tired and for three days injection site pain. Injection site pain started immediately on 24Mar2021. The others 9 days later and may or may not be related to the vaccine. The outcome of all the events were recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1224302
Sex: F
Age:
State: OH

Vax Date: 03/21/2021
Onset Date: 03/01/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 7 days after vaccine I woke with leg weakness. 3 days later my arms are weak; 7 days after vaccine I woke with leg weakness. 3 days later my arms are weak; It is hard to walk or hold; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ER2613) via an unspecified route of administration in left arm on 21Mar2021 18:30 as single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. The patient's medical history included covid-19 prior to vaccination and concomitant medications were not reported. Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine: No. Patient had 7 days after vaccine I woke with leg weakness on 27Mar2021 08:00. 3 days later my arms are weak on. It is hard to walk or hold anything. No treatment was received for the events. The outcome of the events was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1224303
Sex: F
Age:
State: VA

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: She had a horrible rash and cellulitis; patient travelled to Florida and got very sick and went to a clinic there.She had a horrible rash and cellulitis and was treated with antibiotics.She still is not ok but the rash is much better; She had a horrible rash; This is a spontaneous report received from a contactable pharmacist. A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 intramuscular, administered in Arm Left on 17Mar2021 (Batch/Lot Number: ep6955) (at the age of 68-years-old) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was unknown if patient received any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown if patient had been tested for COVID-19. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) dose 1 intramuscular, administered in Arm Left on 25Feb2021 (Batch/Lot Number: EN6200) as a single dose for COVID-19 immunization. On 17Mar2021, the patient travelled to florida and got very sick and went to a clinic there. She had a horrible rash and cellulitis. The events result in doctor or other healthcare professional office/clinic visit. She still was not ok, but the rash was much better. Therapeutic measures were taken as a result of events included antibiotics (unspecified). The outcome of the event rash was recovering, and other events was not recovered.; Sender's Comments: The event cellulitis most likely represents intercurrent medical condition that is assessed as unrelated to BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1224304
Sex: M
Age:
State: NJ

Vax Date: 03/09/2021
Onset Date: 03/20/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Showed a false positive for HIV; This is a spontaneous report from a contactable consumer (patient). A 35-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6205), via an unspecified route of administration in left arm, on 09Mar2021 at 02:00 PM (14:00), at a single dose, for COVID-19 immunization. The patient had no medical history and concomitant medications. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The most recent vaccine was administered in a public health clinic or Veterans administration facility. On 20Mar2021 at 12:00 PM, the patient donated blood at American Red Cross and showed a false positive result for HIV. The confirmatory test in Mar2021 resulted negative. The patient had not received a false positive previously. No treatment was received for the event. The patient underwent COVID-19 nasal swab test post-vaccination on 12Mar2021 that was negative. The patient recovered from the event in Mar2021.

Other Meds:

Current Illness:

ID: 1224305
Sex: F
Age:
State: SC

Vax Date:
Onset Date: 03/24/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Both became positive with covid between doses.; Both became positive with covid between doses.; This is a spontaneous report received from a contactable Consumer. This 40-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for Injection, LOT NUMBER: UNKNWON) via an unspecified route of administration on an unknown date as a SINGLE dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On last Wednesday (24Mar2021), the patient tested positive of COVID-19 virus. The patient became positive with COVID between doses of the Pfizer vaccine. The second dose of BNT162B2 is scheduled for 07Apr2021; hence, the patient wanted to know whether the second dose of BNT162B2 could be rescheduled. Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021361947 same reporter/drug/event, different patient

Other Meds:

Current Illness:

ID: 1224306
Sex: F
Age:
State: TX

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache 1st 24 hours. very tired into the next 48, then 4 days later violent vomiting, Diarrhea, shaking badly with chills, fever of 102, heart racing, shortness of breath, horrible horrible migrain; headache 1st 24 hours. very tired into the next 48, then 4 days later violent vomiting, Diarrhea, shaking badly with chills, fever of 102, heart racing, shortness of breath, horrible horrible migrain; headache 1st 24 hours. very tired into the next 48, then 4 days later violent vomiting, Diarrhea, shaking badly with chills, fever of 102, heart racing, shortness of breath, horrible horrible migrain; headache 1st 24 hours. very tired into the next 48, then 4 days later violent vomiting, Diarrhea, shaking badly with chills, fever of 102, heart racing, shortness of breath, horrible horrible migrain; fever of 102; headache 1st 24 hours. very tired into the next 48, then 4 days later violent vomiting, Diarrhea, shaking badly with chills, fever of 102, heart racing, shortness of breath, horrible horrible migrain; headache 1st 24 hours. very tired into the next 48, then 4 days later violent vomiting, Diarrhea, shaking badly with chills, fever of 102, heart racing, shortness of breath, horrible horrible migrain; headache 1st 24 hours. very tired into the next 48, then 4 days later violent vomiting, Diarrhea, shaking badly with chills, fever of 102, heart racing, shortness of breath, horrible horrible migrain; headache 1st 24 hours. very tired into the next 48, then 4 days later violent vomiting, Diarrhea, shaking badly with chills, fever of 102, heart racing, shortness of breath, horrible horrible migrain; very tired and exhausted; This is a spontaneous report received from contactable consumer. A 61-years-old female patient had taken BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EP6955), via an unspecified route of administration at the right arm on 23Mar2021 18:00 at single dose for COVID-19 immunization. The patient's medical history included thyroid disorder, severe asthma, osteoporosis, heart disease (previous heart attack). The patient had allergies to penicillin, zpac, sulfa drugs, symbicort, hydrocodone, kiwi, shellfish. Concomitant medications included amlodipine besilate, simvastatin, levothyroxine sodium, fluticasone furoate. The patient had headache 1st 24 hours and very tired into the next 48 (on 23Mar2021), then 4 days later (on 27Mar2021) violent vomiting, diarrhoea, shaking badly with chills, fever of 102, heart racing, shortness of breath, horrible migraine (not prone to migraines), was sick for about 36 hours and have been exhausted every since. It was reported that patient was homebound for the most part and no one in my house was sick but me. The patient was not diagnosed with covid prior vaccination not tested since vaccination. Outcome of events was reported as recovered with sequel. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE BESILATE; SIMVASTATIN; LEVOTHYROXINE SODIUM; ARNUITY ELLIPTA

Current Illness:

ID: 1224307
Sex: M
Age:
State: TN

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Prior to vaccine or was asked if any severe reactions occurred to pervious vaccines; post vaccination patient states of light headedness and proceeds to faint onto the floor while pharmacy tech assist; Prior to vaccine or was asked if any severe reactions occurred to pervious vaccines; post vaccination patient states of light headedness and proceeds to faint onto the floor while pharmacy tech assist; This is a spontaneous report from a contactable physician. A 24-years-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: Batch/Lot Number: ER2613; Expiration Date: unknown), dose 1 intramuscular, administered in Arm Left on 30Mar2021 14:30 as SINGLE DOSE for COVID-19 immunization. Medical history included syncope, High blood pressure, Prone to fainting during medical procedures, Bell's palsy on 25Mar2021 with the outcome of not recovered. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was tested for Covid-19 was unknown. The patient was not diagnosed with covid-19 prior to vaccination. The patient's concomitant medications were not reported. No allergies to medications, food, or other products. On 30Mar2021 14:45 the patient experienced light headedness and proceeds to faint onto the floor while pharmacy tech assists to prevent harm. The outcome of the event light headedness and proceeds to faint onto the floor was recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1224308
Sex: F
Age:
State: FL

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Metallic Taste in Mouth; Sweating; Vertigo; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 40-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Brand: Pfizer), dose 1 via an unspecified route of administration in Arm Left on 29Mar2021 16:30 (Lot number and expiry date was not reported) as single dose for covid-19 immunisation. Medical history included hypersensitivity from an unknown date and unknown if ongoing Allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient was not pregnant at the time of vaccination. Prior to vaccination, was the patient diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 29Mar2021 16:45, the patient experienced metallic taste in mouth, sweating and vertigo. Therapeutic measures were not taken as a result of adverse event. The outcome of the event was recovered on an unspecified date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1224309
Sex: F
Age:
State: ME

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Achy; Tired; Cough; This is a spontaneous report received from a contactable consumer (patient). A 68-year-old non pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/Batch number: not reported), via intramuscularly on the left arm on 29Mar2021 04:15 pm at single dose for COVID-19 immunization. Medical history included diverticulitis. The patient was allergic to scopolamine. The patient received other medications within 2 weeks of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. There was no COVID prior vaccination. Previously on an unknown date, patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE). Since the vaccination, patient had not been tested for COVID-19. On 29Mar2021, patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) and on 30Mar2021 at 12 am, the patient reported that she was achy, tired and coughing. The patient did not receive any treatment for the events. The outcome of the events was resolving. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1224310
Sex: F
Age:
State: OH

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness/swollen lymph node under left arm pit the morning after injection along with swollen arm at injection site. Soreness/swollen lymph node is still there 1 week later and has not gone down.; Swollen arm at injection site; Soreness/swollen lymph node under left arm pit; This is a spontaneous report from a contactable consumer (patient). A 40-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EP7534), via an unspecified route of administration in the left arm on 23Mar2021 at 10:30 (at the age of 40-years-old) as a single dose for COVID-19 immunization. The patient medical history included asthma. The patient had allergies to medications, food, or other products which included, shellfish, penicillin, biaxin, ceclor, sulfa, Cephalosporins. Patient reported that she took concomitant medications in two weeks as Mirabegron (MYRBETRIQ). The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021 at 07:00 patient experienced Soreness/swollen lymph node under left arm pit in the morning after the vaccination along with swollen arm at injection site. Patient stated that the Soreness/swollen lymph node is still there 1 week later and has not gone down. The patient not had covid prior vaccination; not tested covid post vaccination. The patient did not receive any treatment for the events. The outcome of events were not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: MYRBETRIQ

Current Illness:

ID: 1224311
Sex: U
Age:
State: FL

Vax Date: 03/22/2021
Onset Date: 03/25/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Reddish whole body rash with severe itching; Reddish whole body rash with severe itching; This is a spontaneous report from a contactable nurse (patient). A 64-year-old patient of an unspecified gender received the second dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in Arm Left on 22Mar2021 09:45 (received at the age of 64-years-old) as single dose for COVID-19 immunization. The vaccine was administered at a hospital. The patient did not receive any vaccine within 4 weeks prior to receiving BNT162B2. The patient had no COVID prior to vaccination and was not tested for COVID post vaccination. Medical history included known allergies: sulfa. Concomitant medication included thyroid (ARMOUR THYROID) taken for an unspecified indication, start and stop date were not reported. The patient previously received the first dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: EL9269), via an unspecified route of administration, administered in Arm Left on 01Mar2021 09:45 (received at the age of 64-years-old) as single dose for COVID-19 immunization. The patient experienced reddish whole body rash with severe itching on 25Mar2021 03:30 PM. Therapeutic measures were taken as a result of reddish whole body rash with severe itching; the patient received oral Benadryl. Outcome of the events was not recovered. It was reported that events resulted into "congenital anomaly" (pending clarification).; Sender's Comments: Based on the information currently available and the product's known safety profile, a possible contributory role of the suspect vaccine BNT162B2 in triggering the onset of "reddish whole body rash with severe itching" cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: ARMOUR THYROID

Current Illness:

ID: 1224312
Sex: M
Age:
State: WA

Vax Date: 03/22/2021
Onset Date: 03/26/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I got the shot and came home ever thing was fine then arm started hurting no big deal then thr headache so bad I had tears in 58. Carpet installer most of my life now that all happened Tuesday felt si; I got the shot and came home ever thing was fine then arm started hurting no big deal then thr headache so bad I had tears in 58. Carpet installer most of my life now that all happened Tuesday felt si; Tuesday felt sick; itching; Crazy itchy once I itch it swells up; I'm broke out all over my arm. And face; This is a spontaneous report from a contactable consumer or other non hcp. A 58-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number was not reported) via an unspecified route of administration, at arm left on 22Mar2021 12:00 as single dose for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. Medical history included high blood pressure. The patient had no allergies to medications, food, or other products. The patient received antibiotics within 2 weeks of vaccination. The patient concomitant medications were not reported. The patient got the shot and came home ever thing was fine then arm started hurting no big deal then the headache so bad I had tears. Carpet installer most of my life now that all happened Tuesday felt sick, we and things seemed instill till about the 26th started itching bad and it got worse and broke out all over my arm and face. Crazy itchy once I itch it swells up. The outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1224313
Sex: F
Age:
State: CA

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching all over, coughing, asthma, anaphylaxis; Itching all over, coughing, asthma, anaphylaxis; Itching all over, coughing, asthma, anaphylaxis; Itching all over, coughing, asthma, anaphylaxis; This is a spontaneous report from a contactable consumer (reporting for herself). A 44-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 20Mar2021 (Batch/Lot Number: Ep-7534) as single dose for COVID-19 immunization. Medical history included seasonal allergy, asthma, and known allergies: penicillin. Concomitant medication included fexofenadine hydrochloride (ALLEGRA); montelukast sodium (SINGULAIR); amlodipine. all taken for an unspecified indication, start and stop date were not reported. The patient previously took grastek for immunomodulatory therapy and experienced drug allergy; bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: En-6198) on 27Feb2021 for COVID-19 immunization. On unspecified date the patient experienced itching all over, coughing, asthma, anaphylaxis. The patient received 2 doses of epinephrine, 100 ml benedryl, and h1h2 bloc. The outcome of the events was recovering. The patient was not tested post vaccination and did not has COVID prior to vaccination.

Other Meds: ALLEGRA; SINGULAIR; AMLODIPINE

Current Illness:

ID: 1224314
Sex: F
Age:
State: TX

Vax Date: 03/12/2021
Onset Date: 03/12/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Bells palsy; Metal taste in mouth, mild on first afternoon but stronger tasting on next two days; her body started to feel strange/ just felt weird; This is a spontaneous report from a non-contactable consumer (patient). A 43-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in left arm, on 12Mar2021 at 02:30pm (at age of 43 years old), as a single dose, for COVID-19 immunisation. Medical history included migraine and high blood pressure. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not have any allergies to medications, food, or other products. Concomitant medications included ondansetron (ZOFRAN) and oxymetazoline hydrochloride (CLARITIN ALLERGIC), Nurtec and allergy immunotherapy; all started on an unspecified date and for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the BNT162b2 vaccine. On 12Mar2021 (at 6:00pm), the patient experienced a metal taste in her mouth, mild on first afternoon but stronger tasting on next two days. On Day 2, it was reported that her body started to feel strange, could not quite describe feeling, further described as it was not really a tired feeling or a painful feeling, just felt weird. On 25Mar2021, the patient experienced Bells palsy. Since the vaccination, the patient has not been tested for COVID-19. Treatment was not received for the events metal taste in her mouth, body started to feel strange/just felt weird. The clinical outcome of the events, metal taste in her mouth, body started to feel strange/ just felt weird, was recovered on an unspecified date. The clinical outcome of the event Bells palsy was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: ZOFRAN [ONDANSETRON]; CLARITIN ALLERGIC

Current Illness:

ID: 1224315
Sex: M
Age:
State: FL

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I am a moderate diabetic but after the injection I have had a considerable increase in fasting and postprandial blood glucose reaching 330.; This is a spontaneous report received from a contactable Health care Professional. A 81-year-old male Patient received received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/batch number and Expiration date: UNKNOWN ), via an unspecified route of administration in left arm on 27Mar2021 15:00 as a single dose for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No Allergies to medications, food, or other products. Concomitant medications within 2 weeks of vaccination included Metformin 850mg, gliclazide 60 mg, detusitol. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. On 28-MAR-2021 at 08:00, the patient stated, I'm diabetic, moderate, but after the injection I've been presenting high fasting and postprandial blood sugar level, reaching to 330. Patient was treated with Glicazide (dose increased). Seriousness of the event was not reported. The outcome of event was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: METFORMIN; GLICLAZIDE; DETRUSITOL

Current Illness:

ID: 1224316
Sex: F
Age:
State:

Vax Date: 03/05/2021
Onset Date: 03/06/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; headache; This is a spontaneous report from a contactable consumer. A 37-years-old female patient received second dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number unknown) via unspecified route on 05Mar2021 as SINGLE DOSE for COVID-19 immunisation. The patient previously took first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number unknown) via unspecified route on an unspecified date as SINGLE DOSE for COVID-19 immunisation. Medical history included ongoing rheumatoid arthritis. The patient's concomitant medications were not reported.06Mar2021, The patient experienced chills and headache. The outcome of events was unknown. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness: Rheumatoid arthritis

ID: 1224317
Sex: F
Age:
State: CO

Vax Date: 12/31/2020
Onset Date: 01/01/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: mid-cycle bleeding two weeks after my first dose; This is a spontaneous report from a contactable Nurse. A non-pregnant 45-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: Batch/Lot Number: EK9231; Expiration Date: unknown), dose 1 via an unspecified route of administration, in Arm Left on 31Dec2020 09:15 as SINGLE DOSE for COVID-19 immunization. The patient received the second dose on 22Jan2021 09:00 AM in left arm (Batch/Lot Number: EL8982). Medical history included sulfa [sulfacetamide sodium; sulfadiazine; sulfadimidine; sulfamerazine]. Sulfa. The patient's concomitant medications were not reported.The patient did not receive any other vaccines within 4 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient did not receive any other vaccines within 4 weeks.The patient did not receive any other vaccines within 2 weeks. In Jan 2021, the patient experienced mid-cycle bleeding two weeks after the first dose (metrorrhagia).The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on 22Mar2021, sars-cov-2 antibody test: positive on 30Mar2021, sars-cov-2 antibody test: negative on 22Mar2021.The outcome of evet was recovering. No follow-up attempts are needed; Information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1224318
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: experienced left arm numbness after vaccine; This is a spontaneous report from a non-contactable consumer (patient). A 35-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Left on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced left arm numbness after vaccine on an unspecified date. The outcome of the event was reported as unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1224319
Sex: F
Age:
State: IL

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Irregular menstruation after 2nd dose/The following day after I received the 2nd shot I started to bleed heavily; This is a spontaneous report received from a contactable consumer (Patient). A 42-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EN6200 and expiration date not provided) via an unspecified route of administration, administered in right arm on 24Mar2021 02:00 PM as SINGLE DOSE for COVID-19 immunization. The patient's medical history was not provided. The patient's historical vaccine included first dose of BNT162B2 (Solution for injection, lot number EN6203 and expiration date not provided) via an unspecified route of administration, administered in right arm as SINGLE DOSE on 03Mar2021 2:00 PM for COVID-19 immunization. There were no allergies to medications, food, or other products. No known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25 Mar 2021, the patient had irregular menstruation after 2nd dose and it was reported that, following day after the patient received the 2nd shot and she started to bleed heavily. Heavy bleeding consisted for 5 days. On the 6th day it stopped. The patient assessed the events as non-serious.cThe adverse event resulted in emergency room. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. On 31 Mar2021, the event was resolved. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1224320
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: contracted COVID days before he was due to receive his 2nd dose of the Pfizer vaccine; contracted COVID days before he was due to receive his 2nd dose of the Pfizer vaccine; This is a spontaneous report from contactable consumer via Pfizer Sales Representative. A 63-years-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. This healthy male contracted COVID days before he was due to receive his 2nd dose of the Pfizer vaccine. The outcome of the event was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1224321
Sex: F
Age:
State: CT

Vax Date: 02/13/2021
Onset Date: 02/19/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Test COVID 19 test/Date 21Feb2021/Result Positive; Test COVID 19 test/Date 21Feb2021/Result Positive; Chills; achy; slight cough; This is a spontaneous report from a contactable consumer (patient's daughter). A 86-year-old female patient received second dose of BNT162B2 (Solution for injection, via intramuscular, administered in left arm on 13Feb2021 (Batch/Lot number: unknown) at single dose for covid-19 immunisation. Medical history included patient is diabetic, congestive heart failure, Oxygen 2 lpm. Concomitant medication was not reported. The patient had a past drug of BNT162B2 for COVID-19 immunisation on Jan2021 at the age of 86-year in left arm via intramuscular. The patient was laying in bed and had cough, achy, chills on 19Feb2021. Patient had both Pfizer COVID-19 vaccinations. The first date was unknown, but believed to be 3 weeks prior to last administration date of 13Feb2021. On 21Feb2021 patient tested positive for COVID-19. Outcome of the event cough, achy, chills was recovered on an unspecified date of 2021 and outcome of other events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1224323
Sex: F
Age:
State: ID

Vax Date: 02/25/2021
Onset Date: 03/01/2021
Rec V Date: 04/18/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pneumonia after getting the COVID Vaccine; Pneumonia was related to MRSA; Very weak; mild fever; This is spontaneous report received from a contactable consumer (patient's husband). A 78-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration at the age of 78-years-old, administered in arm on 25Feb2021 15:45 (Lot Number: EN6202) as single dose for COVID-19 immunization. Medical history included diabetes mellitus from 2011 (Verbatim: Diabetic; Diagnosed 10 years ago), rheumatoid arthritis from 1995 (Verbatim: Rheumatoid arthritis; Diagnosed in 1995), cardiac failure congestive from Oct2020 (Verbatim: Congestive Heart Failure), adrenal insufficiency from 1990 (Verbatim: Adrenal insufficiency; Diagnosed in probably 1990), atrial fibrillation from 2017 (Verbatim: Atrial fibrillation; Diagnosed 4 years ago). Concomitant medication included unspecified medications ("she takes lots of medications. Too long of list she probably takes 15 different medications, reporter chose not to provide them). No-other vaccines were given at the same time. She gets the flu vaccine every year, shingles vaccines, pneumonia vaccines every year but, has no idea where they were manufactured. Confirmed she did not get the listed vaccines at the same time she got the COVID Vaccine. The patient's husband and the patient (his wife) both received their 1st COVID shot on the 25Feb2021 and was scheduled for 3 weeks later. He got his COVID on the 18Mar2021. The patient got Pneumonia and was admitted to the hospital but he does not know the exact time the Pneumonia started. It developed over a period of several day started with a mild fever (in Mar2021) and after the 2nd or 3rd day her fever spiked and that's when she was admitted to the hospital. He reports his wife went into the hospital with Pneumonia on 18Mar2021, the day she was supposed to get the 2nd shot. It was also reported that Pneumonia was related to MRSA. She laid up in the hospital for 2 weeks, the weakness ("very weak") may have happened in the hospital or a few days before, date was confirmed to be on 15Mar2021. The event "pneumonia" was totally unrelated to COVID and now she is in a nursing home, she went in on 26Mar2021. She probably won't be able to have the 2nd shot for a couple of weeks. She was in there for a couple of weeks and still quarantined. He wanted to know will the fact that she is not getting the 2nd shot at the 3-week interval reduce the efficacy of the vaccine since she is getting the 2nd dose late. Does it make a difference with the effectiveness of the vaccine if she's going take the 2nd dose 3-4 weeks or even a month and a half rather than the usual 21 days interval? No treatment before going to the hospital other than calling the doctor and the doctor saying take her to the hospital (not reported if patient received treatment during hospital stay). No treatment done over the weekend, while she was in the nursing home. The adverse event pneumonia required a visit to Emergency Room. The patient was hospitalized from 18Mar2021 to 26Mar2021. Investigations included had a lot of blood work done, a CT scan, an X-ray on unspecified dates. He does not have any of the results but, the physicians have them. The outcome of the event mild fever was unknown, for very weak was not recovered while for the rest of the events was recovered on 26Mar2021.

Other Meds:

Current Illness:

ID: 1224324
Sex: F
Age:
State: ID

Vax Date: 02/25/2021
Onset Date:
Rec V Date: 04/18/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pneumonia; Pneumonia; This is a spontaneous report from a contactable consumer (patient's husband). A 78-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (manufacturer unspecified), via an unspecified route of administration on 25Feb2021 (Batch/Lot number was not reported) as single dose for immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient got pneumonia on an unspecified date; the patient received Pneumonia vaccine a couple of years ago. It was not known the exact time the pneumonia started. It developed over a period of several day started with a mild fever and after the 2nd or 3rd day her fever spiked and that's when she was admitted to the hospital. No treatment done over the weekend, while she was in the nursing home. No treatment before going to the hospital other than calling the doctor and the doctor saying take her to the hospital. The adverse event also resulted in Emergency Room visit. The patient was hospitalized from 18Mar2021 to 26Mar2021. She had a lot of blood work done, a CT scan, an X-ray, the physicians have the result. The outcome of events was recovered on 24Mar2021 (as reported). Pfizer is a marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) in the reporter's country. This may be a duplicate report if another marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) has submitted the same report to the regulatory authorities. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1224325
Sex: M
Age:
State: OH

Vax Date: 02/26/2021
Onset Date: 03/04/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Drooping and closed left eyelid/third nerve ocular palsy paralysis; Headache; Sandy eyes; This is a spontaneous report received from a contactable consumer (Patient) reporting for himself. A 73-year-old patient received second dose of BNT162B2 0.3ml on 26Feb2021 at 12:00 pm (Lot no: EN6203, Expiration date: unknown) via intramuscularly route of administration in right arm as SINGLE DOSE for covid-19 immunization. The patient does not have cardiovascular disease, he just had a blockage at one time. The patient had one stent put in and low dose to preventative for plaque buildup in veins. The patient's concomitant medications included Simvastatin for mild heart attack in 2013. The patient previously vaccinated with first dose of BNT162B2 on 05Feb2021 at 13:00 pm and 5 days later got sandy eye. It was reported that, on 04Mar2021 (3 weeks later of second dose) the patient experienced blurred vision and drooping, closed left eyelid which were diagnosed as third nerve ocular palsy paralysis on 08Mar2021. It was reported that the patient still gets Headaches periodically. The outcome of the events was not recovered. Follow attempts are requested. Further information is expected.

Other Meds: SIMVASTATIN

Current Illness:

ID: 1224326
Sex: F
Age:
State: MI

Vax Date: 03/26/2021
Onset Date: 03/28/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Stated that her knees are killing her. Clarified that her knees are hurting; This is a spontaneous report from a Pfizer-sponsored program XELSOURCE. A contactable consumer (patient) reported for herself that a 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6204), via an unspecified route of administration, administered in Arm Left on 26Mar2021 as single dose for covid-19 immunisation; tofacitinib citrate (XELJANZ 5mg tablet, Batch/Lot Number: EH1886; Expiration Date: Jun2024), oral from an unspecified date 7 to 8 years ago to 26Mar2021 at 5 mg twice daily for rheumatoid arthritis. The patient medical history and concomitant medications were not reported. The patient previously took adalimumab (HUMIRA injection) for rheumatoid arthritis, started 15 years ago and stopped taking it 7-8 years ago permanently, unknown dosage injection to her arm every two weeks and she did not like the shot that she is a big baby; it quit working because she did not take it like she was supposed to. Patient was off of the tofacitinib citrate since last Friday (26Mar2021) since she got the Pfizer Covid vaccine. Stated that her knees were killing her, she could feel her knees when she bended and it was annoying. Clarified that her knees were hurting. It started Sunday night (28Mar2021) that she realized it. When she got up she could feel it. Stated normally she does not have any problems with her knees. When standing from sitting position that she noticed them. She should have said they were not killing her but that they were noticeable. This has been happening without the medication. Stated that she took the medication Thursday night to take the shot Friday morning. Stated that it was about three days later that they started annoying her. She would start back on it on Friday. The doctor wanted her off of it for seven days. The action taken in response to the event for tofacitinib citrate was post-therapy. Outcome of the event was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1224327
Sex: U
Age:
State: TN

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 04/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a lump in my lymph node; severe back pain; fatigue; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration on 26Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 for COVID-19 immunization on an unspecified date. In Mar2021, the patient experienced severe back pain, a lump in my lymph node and fatigue since receiving. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm